TABLE OF CONTENTS

  1. Introduction
    • Definition of HLA Typing Market
    • Scope of the Report
  2. Methodology
    • Executive Summary
    • Market Overview
    • Market Definition and Segmentation
  3. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis
    • PESTEL Analysis
  4. HLA Typing Market, By Technology:
    • Molecular Assay Technologies
      • PCR-based Molecular Assays
        • Sequence-specific Primer-PCR
        • Sequence-specific Oligonucleotide-PCR
        • Other PCR-based Molecular Assays
      • Sequencing-based Molecular Assays
        • Sanger Sequencing
        • Next-generation Sequencing
        • Pyrosequencing
      • Non-molecular Assay Technologies
  5. HLA Typing Market, By Product & Service:
    • Reagents & Consumables
    • Instruments
    • Software & Services
  6. HLA Typing Market, By Application:
    • Diagnostic Applications
    • Research Applications
    • Donor-recipient cross-matching
    • Infectious disease testing
    • Cancer diagnosis & prevention
    • Transfusion therapy
    • Other diagnostic applications
  7. HLA Typing Market, By End User:
    • Commercial service providers
    • Hospitals & surgical centers
    • Research laboratories & academic institutes
  8. HLA Typing Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
  9. Competitive Landscape
  10. Company Profiles
    • Pacbio
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • F. Hoffman-La Roche Ltd.
    • Alpha Biotech Limited
    • Qiagen N.V.
    • Caredx, Inc.
    • Krishgen Biosystems
    • HistogeneticsLlc
    • Creative Biolabs
    • Takara Bio Inc.
    • Omixon Inc.
    • Bio-Rad Laboratories, Inc.
    • Inno-Train Diagnostik GMBH
    • Hansa Biopharma Ab
    • Thermo Fisher Scientific
    • Immucor, Inc.
    • BD
    • TBG Diagnostics Limited
    • GENDX
    • Illumina, Inc.
    • Bag Diagnostics Gmbh
    • Fujirebio
    • Biofortuna Limited
    • Hologic, Inc.
  11. Conclusion and Future Outlook
  12. Appendix
    1. Research Methodology
    2. About the Pharmanucleus

13. Disclaimer



Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.